Literature DB >> 7883224

Quantification of inflammatory bowel disease activity using technetium-99m HMPAO labelled leucocyte single photon emission computerised tomography (SPECT).

M J Weldon1, A M Masoomi, A J Britten, J Gane, C J Finlayson, A E Joseph, J D Maxwell.   

Abstract

Technetium-99m HMPAO labelled white cell bowel uptake was quantified in 23 patients with suspected colitis by means of the novel technique of single photon emission computerised tomography (SPECT) using a standard gamma-camera. Uptake in colon segments was quantified on transaxial images and expressed as a fraction of marrow uptake (SPECT score). Segmental histological disease activity was assessed at colonoscopy (20) or at surgery (3). Segmental histology score correlated with SPECT score r = 0.79 (p < 0.001). Overall SPECT score for all affected segments correlated with Crohn's disease activity index (CDAI) r = 0.66, p = 0.001 and with laboratory activity indices; erythrocyte sedimentation rate r = 0.44, p = 0.03, C reactive protein r = 0.38, p = 0.05, and albumin r = -0.46, p = 0.03. Small bowel SPECT score in 13 patients correlated with CDAI r = 0.65, p < 0.01 but not with erythrocyte sedimentation rate or C reactive protein. Five patients with positive small bowel white cell uptake had normal C reactive protein and erythrocyte sedimentation rate. Overall SPECT score for disease at all sites correlated with both CDAI and with laboratory indices of inflammation. 99mTc HMPAO SPECT provides non-invasive and accurate quantification of inflammatory bowel disease activity in both large and small bowel and may be useful in the objective evaluation of treatment for inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883224      PMCID: PMC1382411          DOI: 10.1136/gut.36.2.243

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

Review 1.  Quantitative SPECT of uptake of monoclonal antibodies.

Authors:  G L DeNardo; D J Macey; S J DeNardo; C G Zhang; T R Custer
Journal:  Semin Nucl Med       Date:  1989-01       Impact factor: 4.446

2.  Imaging inflammation: current role of labeled autologous leukocytes.

Authors:  A M Peters
Journal:  J Nucl Med       Date:  1992-01       Impact factor: 10.057

3.  The 99mTc-HMPAO leukocyte scan: an alternative to radiology and endoscopy in evaluating the extent and the activity of inflammatory bowel disease.

Authors:  F Spinelli; M Milella; R Sara; F Banfi; R Vigorelli; M Possa; G Bianchi Porro; S Ardizzone; L Gallitelli
Journal:  J Nucl Biol Med       Date:  1991 Apr-Jun

Review 4.  Granulocyte kinetics and methods of evaluating cell performance.

Authors:  A M Peters
Journal:  Nucl Med Commun       Date:  1988-10       Impact factor: 1.690

Review 5.  Measurement of activity in Crohn's disease.

Authors:  F D Bartholomeusz; D J Shearman
Journal:  J Gastroenterol Hepatol       Date:  1989 Jan-Feb       Impact factor: 4.029

Review 6.  Radiolabelled granulocytes in inflammatory bowel disease: diagnostic possibilities and clinical indications.

Authors:  W Becker; W Fischbach; M Weppler; B Mosl; G Jacoby; W Börner
Journal:  Nucl Med Commun       Date:  1988-10       Impact factor: 1.690

7.  Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label.

Authors:  J Schölmerich; E Schmidt; C Schümichen; P Billmann; H Schmidt; W Gerok
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

8.  The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime.

Authors:  H J Danpure; S Osman; M J Carroll
Journal:  Nucl Med Commun       Date:  1988-06       Impact factor: 1.690

9.  99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes.

Authors:  A M Peters; M E Roddie; H J Danpure; S Osman; G P Zacharopoulos; P George; A W Stuttle; J P Lavender
Journal:  Nucl Med Commun       Date:  1988-06       Impact factor: 1.690

10.  Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation.

Authors:  A M Peters; H J Danpure; S Osman; R J Hawker; B L Henderson; H J Hodgson; J D Kelly; R D Neirinckx; J P Lavender
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

View more
  9 in total

1.  White cell scanning has a role in imaging small and large bowel.

Authors:  A P Poullis
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

Review 2.  Role of scintigraphy in inflammatory bowel disease.

Authors:  Maria I Stathaki; Sophia I Koukouraki; Nikolaos S Karkavitsas; Ioannis E Koutroubakis
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

3.  Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes.

Authors:  J W Arndt; M I Grootscholten; R A van Hogezand; G Griffioen; C B Lamers; E K Pauwels
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

Review 4.  Influence of treatment on morphological features of mucosal inflammation.

Authors:  K Geboes; I Dalle
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

5.  Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease.

Authors:  A Laghi; O Borrelli; P Paolantonio; L Dito; M Buena de Mesquita; P Falconieri; R Passariello; S Cucchiara
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

6.  99mTc-HMPAO granulocyte scintigraphy in the early detection of postoperative asymptomatic recurrence in Crohn's disease.

Authors:  L Biancone; F Scopinaro; M Ierardi; P Paoluzi; A Marcheggiano; M C Di Paolo; B Porowska; A C Colella; F Pallone
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

7.  A reproducible grading scale for histological assessment of inflammation in ulcerative colitis.

Authors:  K Geboes; R Riddell; A Ost; B Jensfelt; T Persson; R Löfberg
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

8.  Elevated serum values of procollagen III peptide (PIIIP) in patients with ulcerative colitis who will develop pseudopolyps.

Authors:  Zarko Babic; Vjekoslav Jagić; Zvonko Petrović; Ante Bilić; Kapetanović Dinko; Goranka Kubat; Rosana Troskot; Mira Vukelić
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

Review 9.  Imaging Inflammation - From Whole Body Imaging to Cellular Resolution.

Authors:  Tuula Peñate Medina; Jan Philip Kolb; Gereon Hüttmann; Robert Huber; Oula Peñate Medina; Linh Ha; Patricia Ulloa; Naomi Larsen; Arianna Ferrari; Magdalena Rafecas; Mark Ellrichmann; Mariya S Pravdivtseva; Mariia Anikeeva; Jana Humbert; Marcus Both; Jennifer E Hundt; Jan-Bernd Hövener
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.